Who we are

The medical affairs council is a forum for like-minded professionals to connect, collaborate, and learn from each other and propel medical affairs towards a digital future.

The council comprises members drawn from medical affairs, medical operations, medical information, scientific communication, and medical communication functions representing the top healthcare organizations worldwide.

What drives us

Mission

Bring together leaders from the industry to evaluate practical applications of modern technology for increasing organizational efficiency, enhancing communication, and improving compliance

Vision

Help medical affairs organizations embrace technology and innovation through a digital and data-driven model to further unlock growth and maximize impact across internal and external engagements

Members

Mary Alice Dwyer

Mary Alice Dwyer

Council Chair
Ravi Tayi, MD, MPH

Ravi Tayi, MD, MPH

VP, Medical Affairs, Endo Pharmaceuticals
Catrinel Galateanu, MD

Catrinel Galateanu, MD

VP, Head of Global Medical Affairs at UCB
Bill Strickland

Bill Strickland

Senior Director, Elevar Therapeutics
David Tang, PharmD

David Tang, PharmD

VP, AbbVie
Deb Long, MD

Deb Long, MD

Sr. Vice President, Medical Affairs Vertex
Dominick Albano, PharmD, MBA

Dominick Albano, PharmD, MBA

VP, Global Medical Information Pfizer
Isma Benattia, MD, MBA

Isma Benattia, MD, MBA

Vice President Europe Medical Affairs, Amgen
 Jung Hyun Lee, PharmD

Jung Hyun Lee, PharmD

Sr. Director, Medical Information, AstraZeneca
Jennifer Riggins

Jennifer Riggins

Advisor, Eli Lilly
Meg Heim, MBA

Meg Heim, MBA

Former VP, Sanofi
Michael Kavanaugh, BS, MBA

Michael Kavanaugh, BS, MBA

Executive Director, Clinical Development and Medical Affairs Effectiveness and Scientific Communications, Boehringer Ingelheim
Richard Swank, Ph.D

Richard Swank, Ph.D

Executive Director and Head, US Medical Capabilities, Amgen
Robin Winter-Sperry, MD

Robin Winter-Sperry, MD

Global Field Medical Lead, Ipsen
Rick Harms, PharmD

Rick Harms, PharmD

Executive Director Medical Affairs, Merck
Andrew Fariello

Andrew Fariello

VP, Global Medical Capabilities, Oncology, AstraZeneca
Sarah Guadagno

Sarah Guadagno

Vice President, Global Medical Communications, Alexion Pharmaceuticals
Thierry Aupérin

Thierry Aupérin

VP, Medical Communications and Training, Alnylam Pharmaceuticals
Roy Palmer

Roy Palmer

Medical Innovation and Effectiveness Lead
Pfizer